| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.5 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |